English Polski
Vol 16, No 1 (2021)
Case report
Published online: 2021-02-27

open access

Page views 476
Article views/downloads 510
Get Citation

Connect on Social Media

Connect on Social Media

Acute kidney injury and thrombotic microangiopathy caused by malignant hypertension in a 21-year-old patient

Patrycja Cecha1, Ada Bielejewska1, Arkadiusz Bociek1, Andrzej Jaroszyński1
Folia Cardiologica 2021;16(1):51-54.


We present a case of a severe cardiovascular emergency in a 21-year-old patient — malignant hypertension complicated by acute kidney injury and thrombotic microangiopathy.

Article available in PDF format

View PDF Download PDF file


  1. Williams B, Mancia G, Spiering W, et al. Authors/Task Force Members:. 2018 ESC/ESH Guidelines for the management of arterial hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension: The Task Force for the management of arterial hypertension of the European Society of Cardiology and the European Society of Hypertension . J Hypertens. 2018; 36(10): 1953–2041.
  2. Cremer A, Amraoui F, Lip GYH, et al. From malignant hypertension to hypertension-MOD: a modern definition for an old but still dangerous emergency. J Hum Hypertens. 2016; 30(8): 463–466.
  3. Rubin S, Cremer A, Boulestreau R, et al. Malignant hypertension: diagnosis, treatment and prognosis with experience from the Bordeaux cohort. J Hypertens. 2019; 37(2): 316–324.
  4. Januszewicz A, Guzik T, Prejbisz A, et al. Malignant hypertension: new aspects of an old clinical entity. Pol Arch Med Wewn. 2016; 126(1-2): 86–93.
  5. Stawicka A, Skonieczny G. Przypadek kliniczny złośliwego nadciśnienia tętniczego z zespołem odwracalnej encefalopatii tylnej u pacjentki z toczniem rumieniowatym układowym oraz zespołem antyfosfolipidowym. Folia Cardiol. 2018; 12(B): 26–29.
  6. Shantsila A, Lip GYH. Malignant hypertension revisited — does this still exist? Am J Hypertens. 2017; 30(6): 543–549.
  7. Amraoui F, Van Der Hoeven NV, Van Valkengoed IGM, et al. Mortality and cardiovascular risk in patients with a history of malignant hypertension: a case-control study. J Clin Hypertens (Greenwich). 2014; 16(2): 122–126.
  8. Khanal N, Dahal S, Upadhyay S, et al. Differentiating malignant hypertension-induced thrombotic microangiopathy from thrombotic thrombocytopenic purpura. Ther Adv Hematol. 2015; 6(3): 97–102.
  9. Timmermans SA, Abdul-Hamid MA, Vanderlocht J, et al. Limburg Renal Registry. Patients with hypertension-associated thrombotic microangiopathy may present with complement abnormalities. Kidney Int. 2017; 91(6): 1420–1425.